Euslim

Euslim is used together with a reduced-calorie diet and weight maintenance to treat obesity in people with certain risk factors (such as diabetes, high blood pressure, and high cholesterol or triglycerides).

Euslim is a reversible inhibitor of lipases. It exerts its therapeutic activity in the lumen of the stomach and small intestine by forming a covalent bond with the active serine residue site of gastric and pancreatic lipases. The inactivated enzymes are thus unavailable to hydrolyze dietary fat in the form of triglycerides into absorbable free fatty acids and monoglycerides. As undigested triglycerides are not absorbed, the resulting caloric deficit may have a positive effect on weight control. Systemic absorption of Euslim is therefore not needed for activity.

Continuous therapy of obese people or patients with overweight, including people having associated with adiposity risk factors, in a combination with moderate hypo caloric diet. In a combination with hypoglycemic medicines (Metformin, Sulfonylurea drugs and/or insulin) or with moderate hypo caloric diet in patents having 2 type of diabetes and overweight or adiposity.

It is not recommended to use Euslim if you: are allergic to any ingredient in Euslim; constantly have problems absorbing food (chronic malabsorption); have gallbladder problems; have cholestasis (a problem of bile flow from the liver to the intestines);

Bowel movement urgency; gas with discharge; inability to control bowel movements; increased number of bowel movements; oily discharge; oily or fatty stools; oily spotting.

Other serious side effects: severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe or persistent stomach pain.

Side effects, including risk of bleeding may be increased if taking anticoagulants simultaneously with Orlistat.

Euslim may seriously decrease Cyclosporine’s effectiveness. Cyclosporine should be taken at least 2 hours before or after orlistat to ensure maximum absorption of cyclosporine into the bloodstream.

 

How Euslim Works

Orlistat is a reversible lipase inhibitor that acts locally in the gastrointestinal tract. It binds covalently to the active serine site of pancreatic and gastric lipases, inactivating these enzymes so they cannot break down dietary triglycerides. As a result, approximately 25–30% of the fat consumed is excreted undigested in the stool. Since the body does not absorb this fat, orlistat creates a negative caloric balance that can facilitate gradual weight loss. Importantly, orlistat does not suppress appetite or act systemically – its effect is entirely in the gut. [EMA][2] and [FDA][16] reviews confirm orlistat’s mechanism: patients essentially waste a fraction of ingested fat, aiding weight reduction.

 External Resources

For more information about orlistat and safe weight loss:
– U.S. National Library of Medicine 

product label
– patient-friendly guide

Always consult a healthcare professional before starting or changing any medication. This information is intended as a general overview and should not replace personalized medical advice.

Sources: Official prescribing information and clinical reviews of orlistat.

Note: This comparison table is for informational purposes. Costs vary by region and insurance; check local pricing. Always consult a healthcare provider before starting or switching weight-loss medication. The efficacy and suitability depend on individual health profile and guidelines.

Conclusion: Euslim (orlistat) is an effective adjunct for weight loss when used as directed with diet and exercise. It is well-studied and recommended by health authorities for appropriate patients. Like all medications, it requires correct usage and monitoring. Patients should understand the gastrointestinal effects and take lifestyle measures to achieve safe weight loss. For more detailed information on orlistat (Euslim), see the FDA prescribing information and the NHS “Weight-loss medicine: Orlistat” guide. Any uncertainties about using this drug should be discussed with a qualified healthcare professional.